Showing 1 - 11 results of 11 for search 'G. M. Teletaeva', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Successful treatment of high-risk gestational trophoblastic disease in a patient with intolerance to standard chemotherapy (clinical case) by G. M. Teletaeva, E. A. Ulrikh, D. Kh. Latipova, A. I. Semenova, E. V. Levchenko, D. G. Ulrikh, I. V. Berlev, T. Yu. Semiglazova, S. A. Protsenko, A. F. Urmancheeva
Published 2021-01-01
Article -
7
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer by T Yu Semiglazova, V A Klyuge, V V Semiglazov, G M Teletaeva, P V Krivorotko, G A Dashyan, R M Paltuev, E V Tkachenko, R V Donskikh, V F Semiglazov
Published 2016-06-01
Article -
8
Trophoblastic neoplasia on the background of developing pregnancy: a rare gynecological tumor with a chance of favorable outcome for mother and fetus by E. A. Ulrikh, E. L. Dikareva, A. D. Dzharbaeva, O. A. Zhamborova, T. M. Pervuninа, E. V. Komlichenko, S. A. Protsenko, G. M. Teletaeva, O. A. Li, A. S. Artemyeva, I. A. Mashenko, G. F. Kutusheva, T. Yu. Semiglazova, А. F. Urmancheeva
Published 2022-12-01
Article -
9
NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES by T. Y. SEMIGLAZOVA, V. A. KLYUGE, E. A. KOROBEYNIKOVA, P. V. KRIVOROTKO, R. M. PALTUEV, G. M. TELETAEVA, D. H. LATIPOVA, V. V. KLIMENKO, E. V. TACHENKO, A. V. Novik, A. I. SEMENOVA, V. V. SEMIGLAZOV, S. A. PROTSENKO, V. F. SEMIGLAZOV
Published 2017-06-01
Article -
10
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia by N. S. Besova, T. A. Titova, E. V. Artamonova, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukal’chuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, A. A. Tryakin, I. S. Stilidi
Published 2019-12-01
Article -
11
Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA t... by N. S. Besova, T. A. Titova, Е. V. Artamonova, A. A. Tryakin, D. L. Stroyakovskiy, E. V. Perminova, D. Yu. Yukalchuk, D. M. Ponomarenko, N. P. Belyak, R. V. Orlova, G. M. Teletaeva, E. Yu. Ratner, A. S. Mochalova, O. O. Gordeeva, A. S. Zhabina, S. V. Gamayunov, A. V. Smolin, A. Yu. Povyshev, M. I. Andrievskikh, I. S. Stilidi
Published 2020-07-01
Article